PGR

progesterone receptor, the group of Nuclear receptor subfamily 3 group C

Basic information

Region (hg38): 11:101029624-101129813

Links

ENSG00000082175NCBI:5241OMIM:607311HGNC:8910Uniprot:P06401AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PGR gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PGR gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
8
clinvar
14
missense
40
clinvar
1
clinvar
5
clinvar
46
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 40 7 13

Variants in PGR

This is a list of pathogenic ClinVar variants found in the PGR region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-101039138-G-T not specified Uncertain significance (Sep 26, 2022)2351123
11-101041987-C-T Benign (Jul 05, 2018)769806
11-101051458-T-C not specified Uncertain significance (May 18, 2022)2290442
11-101062583-C-T not specified Uncertain significance (Apr 23, 2024)3306040
11-101062676-G-A Benign (May 24, 2018)722198
11-101062677-C-T not specified Uncertain significance (May 28, 2024)3306035
11-101062708-G-C Benign (Aug 07, 2018)720193
11-101091797-G-T Benign (Aug 04, 2018)771450
11-101125999-G-A Benign (Aug 16, 2018)785890
11-101126013-T-C not specified Uncertain significance (Aug 30, 2021)2247482
11-101126118-C-T not specified Uncertain significance (Mar 01, 2024)3211900
11-101126126-T-C not specified Uncertain significance (Mar 25, 2024)3306038
11-101127443-T-C not specified Uncertain significance (Feb 05, 2024)3211899
11-101127456-G-A not specified Uncertain significance (Aug 12, 2021)2243348
11-101127464-T-G Benign (Nov 20, 2018)716972
11-101127496-G-A Likely benign (Apr 11, 2018)738291
11-101127596-C-A not specified Uncertain significance (Feb 22, 2023)2460067
11-101127599-G-C not specified Uncertain significance (May 04, 2022)2287293
11-101127627-C-T not specified Uncertain significance (Dec 16, 2023)3211897
11-101127633-A-C not specified Uncertain significance (Aug 12, 2021)2243948
11-101127728-A-G not specified Uncertain significance (Nov 22, 2021)2346975
11-101127748-G-C Likely benign (Jun 26, 2018)710125
11-101127766-C-G Likely benign (Jun 08, 2018)713816
11-101127770-G-C not specified Uncertain significance (Jun 19, 2024)2204881
11-101127800-G-C not specified Uncertain significance (Dec 21, 2022)2352287

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PGRprotein_codingprotein_codingENST00000325455 8100901
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.05100.9491257310171257480.0000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.284265070.8400.00002425880
Missense in Polyphen121202.080.598782475
Synonymous-0.4352242161.040.00001061983
Loss of Function3.91933.40.2690.00000165403

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008810.0000881
Ashkenazi Jewish0.000.00
East Asian0.0001710.000163
Finnish0.00009630.0000924
European (Non-Finnish)0.00005340.0000527
Middle Eastern0.0001710.000163
South Asian0.00006700.0000653
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as transcriptional activator or repressor. {ECO:0000269|PubMed:10757795, ECO:0000269|PubMed:1587864, ECO:0000269|PubMed:9407067, ECO:0000305}.; FUNCTION: Isoform B: Transcriptional activator of several progesteron-dependent promoters in a variety of cell types. Involved in activation of SRC-dependent MAPK signaling on hormone stimulation. {ECO:0000269|PubMed:7969170}.;
Pathway
Oocyte meiosis - Homo sapiens (human);Breast cancer - Homo sapiens (human);Estrogen signaling pathway - Homo sapiens (human);Progesterone-mediated oocyte maturation - Homo sapiens (human);NHR;Nuclear Receptors;Signaling by ERBB4;Ovarian Infertility Genes;Signal Transduction;Gene expression (Transcription);how progesterone initiates the oocyte maturation;Generic Transcription Pathway;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular responses to stress;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Nuclear signaling by ERBB4;Signaling by ERBB4;Signaling by Receptor Tyrosine Kinases;ESR-mediated signaling;Validated nuclear estrogen receptor alpha network;Cellular roles of Anthrax toxin (Consensus)

Recessive Scores

pRec
0.530

Haploinsufficiency Scores

pHI
0.139
hipred
Y
hipred_score
0.834
ghis
0.398

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.499

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pgr
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); neoplasm; embryo phenotype;

Zebrafish Information Network

Gene name
pgr
Affected structure
oocyte stage V
Phenotype tag
abnormal
Phenotype quality
non-functional

Gene ontology

Biological process
ovulation from ovarian follicle;epithelial cell maturation;transcription initiation from RNA polymerase II promoter;signal transduction;cell-cell signaling;negative regulation of gene expression;paracrine signaling;positive regulation of transcription by RNA polymerase II;lung alveolus development;regulation of epithelial cell proliferation;progesterone receptor signaling pathway;tertiary branching involved in mammary gland duct morphogenesis
Cellular component
nucleoplasm;mitochondrial outer membrane;cytosol
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;steroid hormone receptor activity;nuclear receptor activity;steroid binding;protein binding;zinc ion binding;enzyme binding;identical protein binding;ATPase binding